| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| Revenue | $2.05B | +8.9% |
| Cost of Revenue | $345.4M | +3.2% |
| Gross Profit | $1.71B | +10.2% |
| R&D Expense | $283.4M | +16.8% |
| SG&A Expense | $1.14B | +24.6% |
| Operating Income | $567.2M | -10.6% |
| Interest Expense | $3.4M | +0.0% |
| Pre-tax Income | $619.4M | -4.6% |
| Income Tax | $166.0M |
| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $370.0M | -8.0% |
| Accounts Receivable | $44.9M | +14.5% |
| Inventory | $1.7M | +21.4% |
| Current Assets | $5.84B | +35.6% |
| Total Assets | $7.60B | +29.7% |
| Current Liabilities | $5.37B | +37.4% |
| Total Liabilities | $5.87B | +37.0% |
| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | $678.9M | +27.2% |
| Capital Expenditures | $270.9M | +40.4% |
| Investing Cash Flow | -$611.2M | -2653.2% |
| Financing Cash Flow | $1.02B | -7.8% |
| Free Cash Flow | $408.0M | +19.6% |
| +12.9% |
| Net Income | $453.4M | -9.7% |
| EPS (Basic) | $8.13 | -9.0% |
| EPS (Diluted) | $8.08 | -9.4% |
| Stockholders' Equity |
| $1.73B |
| +9.9% |